Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc.

NEUP
Neuphoria Therapeutics Inc.US flagNASDAQ Global Market
4.63
USD
+0.16
(+3.58%)
-0.08EPS
-57.87P/E
7.54MMarket Cap
Mar 13Next Earn

Neuphoria Therapeutics Inc. (NEUP) Stock Splits

Learn about Neuphoria Therapeutics Inc.'s most recent 1-for-12 basis stock split on December 24, 2024. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Neuphoria Therapeutics Inc.'s most recent stock split

Split Date: 2024-12-24
Split Ratio: 1:12
Price Before Split: $0.55
Price After Split: $0.05

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 12.00 times fewer shares (a 1:12 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Neuphoria Therapeutics Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-12-241:12Yes$0.55$0.05

About Neuphoria Therapeutics Inc.

Company overview and industry information

Neuphoria Therapeutics Inc. (NEUP) operates in the Medical - Pharmaceuticals industry. The recent 1-for-12 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Medical - Pharmaceuticals
Go to Neuphoria Therapeutics Inc. Summary

Last updated: 2/13/2025

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.